Potential Use of a POCT for the Direct Transfer of Stroke Patients From the Ambulance to the Thrombectomy Center

NCT05833945 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 355

Last updated 2024-11-18

No results posted yet for this study

Summary

Stroke is the leading cause of long-term disability and the second most common cause of death worldwide. Currently, the protocols require the imaging techniques at the hospitals to differ ischemic strokes with large vessel occlusion (LVO) from others. In this study, a duplex POC will be used in combination with an APP to identify LVO ischemic strokes in a 800 patients'cohort with pre-hospital and in-hospital blood samples.

Conditions

  • Stroke, Acute Ischemic

Interventions

DEVICE

Large Vessel Occlusion Biomarkers Test

Duplex Point of Care test to measure the concentration of biomarkers associated to Large Vessel Occlusion in blood samples used in combination with an APP.

Sponsors & Collaborators

  • Hospital Universitario Virgen Macarena

    collaborator OTHER
  • Hospitales Universitarios Virgen del Rocío

    collaborator OTHER
  • Hospital Universitario Torrecárdenas

    collaborator OTHER
  • Hospital Universitario Poniente

    collaborator UNKNOWN
  • Hospital Clínico Universitario Lozano Blesa

    collaborator OTHER
  • Hospital Miguel Servet

    collaborator OTHER
  • Hospital Universitario Royo Villanova

    collaborator UNKNOWN
  • Hospital General San Jorge

    collaborator UNKNOWN
  • Hospital San Pedro de Logroño

    collaborator OTHER
  • Hospital Clínico Universitario de Valladolid

    collaborator OTHER
  • Hospital Universitario La Fe

    collaborator OTHER
  • Complejo Hospitalario Universitario de Albacete

    collaborator OTHER
  • Hospital de Medina del Campo

    collaborator UNKNOWN
  • Hospital General Río Carrión

    collaborator UNKNOWN
  • Hospital General de Segovia

    collaborator OTHER
  • Hospital del Rio Hortega

    collaborator OTHER
  • Fundación Pública Andaluza para la gestión de la Investigación en Sevilla

    lead OTHER

Principal Investigators

  • Ana Barragán Prieto · Hospital Universitario Virgen Macarena

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-04-15
Primary Completion
2024-01-31
Completion
2024-04-24

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05833945 on ClinicalTrials.gov